Efficient adeno-associated virus-mediated (AAV-mediated) gene delivery remains a significant obstacle to effective retinal gene therapies. Here, we apply directed evolution - guided by deep sequencing and followed by direct in vivo secondary selection of high-performing vectors with a GFP-barcoded library - to create AAV viral capsids with the capability to deliver genes to the outer retina in primates. A replication-incompetent library, produced via providing rep in trans, was created to mitigate risk of AAV propagation. Six rounds of in vivo selection with this library in primates - involving intravitreal library administration, recovery of genomes from outer retina, and extensive next-generation sequencing of each round - resulted in vec...
There is much debate on the adeno-associated virus (AAV) serotype that best targets specific retinal...
There is much debate on the adeno-associated virus (AAV) serotype that best targets specific retinal...
Abstract Gene therapy using recombinant adeno‐associated virus (rAAV) vectors to treat blinding reti...
Efficient AAV-mediated gene delivery remains a significant obstacle to effective retinal gene therap...
International audienceIntraocular injection of adeno-associated viral (AAV) vectors has been an evid...
Current retinal gene therapies using adeno-associated viral (AAV) vectors are limited in their effic...
Inherited retinal degenerations, effecting about 1:3000 people, have historically been challenging t...
Inherited retinal degenerations, effecting about 1:3000 people, have historically been challenging t...
Gene transfer using adeno-associated viruses (AAVs) has been effective for treating inherited retina...
Adeno-associated viral vectors (AAV) have been shown to be safe in the treatment of retinal degenera...
There is much debate on the adeno-associated virus (AAV) serotype that best targets specific retinal...
Adeno-associated viral vectors (AAV) have been shown to be safe in the treatment of retinal degenera...
Adeno-associated viral vectors (AAV) have been shown to be safe in the treatment of retinal degenera...
There is much debate on the adeno-associated virus (AAV) serotype that best targets specific retinal...
<div><p>Adeno-associated viral vectors (AAV) have been shown to be safe in the treatment of retinal ...
There is much debate on the adeno-associated virus (AAV) serotype that best targets specific retinal...
There is much debate on the adeno-associated virus (AAV) serotype that best targets specific retinal...
Abstract Gene therapy using recombinant adeno‐associated virus (rAAV) vectors to treat blinding reti...
Efficient AAV-mediated gene delivery remains a significant obstacle to effective retinal gene therap...
International audienceIntraocular injection of adeno-associated viral (AAV) vectors has been an evid...
Current retinal gene therapies using adeno-associated viral (AAV) vectors are limited in their effic...
Inherited retinal degenerations, effecting about 1:3000 people, have historically been challenging t...
Inherited retinal degenerations, effecting about 1:3000 people, have historically been challenging t...
Gene transfer using adeno-associated viruses (AAVs) has been effective for treating inherited retina...
Adeno-associated viral vectors (AAV) have been shown to be safe in the treatment of retinal degenera...
There is much debate on the adeno-associated virus (AAV) serotype that best targets specific retinal...
Adeno-associated viral vectors (AAV) have been shown to be safe in the treatment of retinal degenera...
Adeno-associated viral vectors (AAV) have been shown to be safe in the treatment of retinal degenera...
There is much debate on the adeno-associated virus (AAV) serotype that best targets specific retinal...
<div><p>Adeno-associated viral vectors (AAV) have been shown to be safe in the treatment of retinal ...
There is much debate on the adeno-associated virus (AAV) serotype that best targets specific retinal...
There is much debate on the adeno-associated virus (AAV) serotype that best targets specific retinal...
Abstract Gene therapy using recombinant adeno‐associated virus (rAAV) vectors to treat blinding reti...